Drug: Bevacizumab Injury: Hyperglycaemia Quarter: 2016Q3
Total Records: 20 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
117881922 | Bevacizumab | Hyperglycaemia | ROCHE | 56.00 YR | F | 100 KG | 20160927 | US |
125483631 | BEVACIZUMAB | Hyperglycaemia | MERCK | 0.00 | 0 | 20160712 | US | |
125620512 | BEVACIZUMAB | Hyperglycaemia | MERCK | 0.00 | 0 | 20160725 | US | |
126009073 | Bevacizumab | Hyperglycaemia | ROCHE | 0.00 | 0 | 20160901 | US | |
127335871 | Bevacizumab | Hyperglycaemia | ROCHE | 0.00 | F | 0 | 20160912 | US |
127410471 | Bevacizumab | Hyperglycaemia | ROCHE | 79.97 YR | M | 77 KG | 20160914 | US |
127413061 | Bevacizumab | Hyperglycaemia | ROCHE | 56.00 YR | F | 48 KG | 20160914 | US |
127413181 | Bevacizumab | Hyperglycaemia | ROCHE | 72.00 YR | M | 84 KG | 20160914 | US |
127414771 | Bevacizumab | Hyperglycaemia | ROCHE | 59.00 YR | F | 108 KG | 20160914 | US |
127448851 | Bevacizumab | Hyperglycaemia | ROCHE | 61.00 YR | F | 64 KG | 20160915 | US |
127538811 | Bevacizumab | Hyperglycaemia | ROCHE | 56.00 YR | M | 77 KG | 20160916 | US |
127540771 | Bevacizumab | Hyperglycaemia | ROCHE | 52.00 YR | M | 90 KG | 20160916 | US |
127543361 | Bevacizumab | Hyperglycaemia | ROCHE | 72.08 YR | M | 81 KG | 20160916 | US |
127825681 | Bevacizumab | Hyperglycaemia | ROCHE | 76.00 YR | F | 58 KG | 20160927 | US |
127905841 | Bevacizumab | Hyperglycaemia | ROCHE | 56.00 YR | F | 69 KG | 20160929 | US |
127907991 | Bevacizumab | Hyperglycaemia | ROCHE | 65.00 YR | F | 100 KG | 20160929 | US |
127911541 | Bevacizumab | Hyperglycaemia | ROCHE | 63.00 YR | F | 69 KG | 20160929 | US |
127973361 | Bevacizumab | Hyperglycaemia | ROCHE | 56.00 YR | F | 76 KG | 20160929 | US |
127986121 | Bevacizumab | Hyperglycaemia | ROCHE | 62.00 YR | F | 72 KG | 20160930 | US |
877635412 | Bevacizumab | Hyperglycaemia | ROCHE | 0.00 | 0 | 20160916 | DE |
Total Records: 20 Number of Pages: 1